Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (1049)

« Back to Publications

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational data.

Hagedoorn NN. et al, (2026), Vaccine, 85

Willingness to accept paediatric blood sample collection for clinical research purposes in Nepal: a qualitative study.

Dahal A. et al, (2026), BMJ Glob Health, 11

Predicting trajectories of illness using RNA velocity of whole blood.

Dunican C. et al, (2026), Nat Commun, 17

Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage at 1-year post-vaccination on rechallenge with Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a controlled human infection study and longitudinal follow-up of a randomised controlled trial.

Chirwa AE. et al, (2026), Lancet Microbe, 7

Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.

Jones E. et al, (2026), J Immunol, 215

Correction: Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Walker J. et al, (2026), PLoS Negl Trop Dis, 20

The association between vaccine coverage and herd protection: exploratory analyses of a cluster-randomised trial of Vi conjugate vaccine.

Zhang Y. et al, (2026), EClinicalMedicine, 94

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Bijukchhe SM. et al, (2026), Lancet Infect Dis

Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.

Hausdorff WP. et al, (2026), Vaccine, 75

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.

Cheliotis KS. et al, (2026), Vaccine, 75

The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.

Liatsikos K. et al, (2026), Lancet Microbe, 7

Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UK.

Kudowa E. et al, (2026), NPJ Vaccines

An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.

Dold C. et al, (2026), Mol Ther

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections

Hagedoorn N. et al, (2026)

Nasal Gene Expression in ART-Naive Adults with HIV and Pulmonary Tuberculosis in Uganda.

Khambati N. et al, (2026), medRxiv

Load More

1
2
3
4
5
6
7
...
»